Search Icon


Drug Information

Product NDC: 0037-6010

Proprietary Name: Edluar

Non Proprietary Name: Zolpidem Tartrate

Active Ingredient(s):

Administration Route(s): ORAL

Dosage Form(s): TABLET

Pharmacy Class(es):
  • Central Nervous System Depression [PE];
  • GABA A Agonists [MoA];
  • Pyridines [CS];
  • gamma-Aminobutyric Acid-ergic Agonist [EPC]

Labeler Information

Labeler Name: Meda Pharmaceuticals Inc.
FDA Application Number: NDA021997
Marketing Category: NDA
Start Marketing Date:7/24/2009
DEA Schedule:CIV

Package Information

No. Package Code Package Description Billing Unit
10037-6010-0220 BLISTER PACK in 1 BOX, UNIT-DOSE (0037-6010-02) / 2 TABLET in 1 BLISTER PACK
20037-6010-303 BLISTER PACK in 1 CARTON (0037-6010-30) / 10 TABLET in 1 BLISTER PACKEA
30037-6010-935 BLISTER PACK in 1 CARTON (0037-6010-93) / 6 TABLET in 1 BLISTER PACK (0037-6010-35)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC0037-6010The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEEdluarThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEZolpidem TartrateThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLETThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE7/24/2009This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMENDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at under Structured Product Labeling Resources.
APPLICATION NUMBERNDA021997This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEMeda Pharmaceuticals Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEZOLPIDEM TARTRATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
PHARM CLASSESCentral Nervous System Depression [PE], GABA A Agonists [MoA], Pyridines [CS], gamma-Aminobutyric Acid-ergic Agonist [EPC] 
DEA SCHEDULECIVThis is the assigned DEA Schedule number as reported by the labeler. Values are CI, CII, CIII, CIV, and CV.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023